Literature DB >> 3034934

Oncogene amplification and chromosomal abnormalities in small cell lung cancer.

J M Ibson, J J Waters, P R Twentyman, N M Bleehen, P H Rabbitts.   

Abstract

Twelve cell lines isolated from patients with small cell lung cancer have been studied for amplification of the three characterised members of the myc proto-oncogene family (c-myc, N-myc, and L-myc) and for abnormalities of chromosome 3. Ten of these lines were being studied for the first time. Ten of the 12 small cell lung cancer cell lines had amplification of one member of the myc proto-oncogene family. Amplification of c-myc was observed in only one small cell lung line--a "morphological variant". One "classic" small cell lung cancer line expressed c-myc but had no obvious amplification of the gene. N-myc and L-myc were more commonly amplified than c-myc. Chromosomal abnormalities (mainly deletions) in chromosome 3 were observed in all small cell lung carcinoma cell lines examined. When the small cell lung carcinoma lines were grouped according to "classic" or "variant" characteristics, it was found that the "classics" had deletions of the short arm of chromosome 3, whereas the "biochemical variants" had deletions of the long arm of chromosome 3. The extent of the deletions varied between cell lines. For the deletion in the short arm of chromosome 3 the minimum common region of overlap was assigned to bands 3p23-3p24.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034934     DOI: 10.1002/jcb.240330405

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

Review 1.  Molecular biology of lung cancer: clinical implications.

Authors:  Jill E Larsen; John D Minna
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

2.  Characterization of ligand binding and processing by gastrin-releasing peptide receptors in a small-cell lung cancer cell line.

Authors:  C Cardona; N M Bleehen; J G Reeve
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

3.  Cellular protoonocogenes are infrequently amplified in untreated non-small cell lung cancer.

Authors:  R J Slebos; S G Evers; S S Wagenaar; S Rodenhuis
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

4.  Multidrug resistance-associated antigens on drug-sensitive and -resistant human tumour cell lines.

Authors:  S E Mirski; S P Cole
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

5.  Chemosensitivity testing of small cell lung cancer using the MTT assay.

Authors:  B G Campling; J Pym; H M Baker; S P Cole; Y M Lam
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

6.  Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines?

Authors:  B G Campling; K Baer; H M Baker; Y M Lam; S P Cole
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.